Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-04

Clinical Trial Update: A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SB-743921 (SB-743921)

Snippet

Sponsor: Cytokinetics | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-04